| Symbol | NEPH |
|---|---|
| Name | NEPHROS INC |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Surgical & Medical Instruments & Apparatus |
| Address | 380 LACKAWANNA PLACE, SOUTH ORANGE, NJ 07079 |
| Telephone | 201.343.5202 |
| Fax | — |
| — | |
| Website | https://www.nephros.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001196298 |
| Description | Nephros Inc is a commercial stage company that develops and sells high performance liquid purification filters for both medical device and commercial markets. Additional info from NASDAQ: |
WEXFORD CAPITAL LP 🟡 adjusted position in 3.0K shares (1 derivative) of NEPHROS INC (NEPH) at $3.60 Transaction Date: Aug 18, 2026 | Filing ID: 015086
Read moreNephros Announces Strong Financial Results for Quarter Ended June 30, 2026
Read moreNephros to Participate in the “Health, Wellness & Longevity” Virtual Conference
Read moreNephros to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22nd at 10:00 a.m. ET
Read more